A new year of investing insights.
ResMed has a minority stake in Nyxoah who are developing a neurostimulation implant to treat OSA. Although we see little near ...
Pleas note: we will be discontinuing the Global Markets Report after 28 February. Australian shares are set to open lower, ...
When it comes to individual shares, avoiding big losers is every bit as important as finding winners. This quick test could make that easier.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback